Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function.

Moore SF, Smith NR, Blair TA, Durrant TN, Hers I.

Sci Rep. 2019 Feb 6;9(1):1468. doi: 10.1038/s41598-018-37012-9.

2.

Phenotype description and response to thrombopoietin receptor agonist in DIAPH1-related disorder.

Westbury SK, Downes K, Burney C, Lozano ML, Obaji SG, Toh CH, Sevivas T, Morgan NV, Erber WN, Kempster C, Moore SF, Thys C, Papadia S, Ouwehand WH; NIHR BioResource–Rare Diseases, Laffan MA, Gomez K, Freson K, Rivera J, Mumford AD.

Blood Adv. 2018 Sep 25;2(18):2341-2346. doi: 10.1182/bloodadvances.2018020370. No abstract available.

3.

Stroke and dementia risk: A systematic review and meta-analysis.

Kuźma E, Lourida I, Moore SF, Levine DA, Ukoumunne OC, Llewellyn DJ.

Alzheimers Dement. 2018 Nov;14(11):1416-1426. doi: 10.1016/j.jalz.2018.06.3061. Epub 2018 Aug 31.

4.

Phosphoinositide 3-kinase p110α negatively regulates thrombopoietin-mediated platelet activation and thrombus formation.

Blair TA, Moore SF, Walsh TG, Hutchinson JL, Durrant TN, Anderson KE, Poole AW, Hers I.

Cell Signal. 2018 Oct;50:111-120. doi: 10.1016/j.cellsig.2018.05.005. Epub 2018 May 21.

PMID:
29793021
5.

Aquaporin-1 regulates platelet procoagulant membrane dynamics and in vivo thrombosis.

Agbani EO, Williams CM, Li Y, van den Bosch MT, Moore SF, Mauroux A, Hodgson L, Verkman AS, Hers I, Poole AW.

JCI Insight. 2018 May 17;3(10). pii: 99062. doi: 10.1172/jci.insight.99062. eCollection 2018 May 17.

6.

Harnessing the power of intelligent machines to enhance primary care.

Moore SF, Hamilton W, Llewellyn DJ.

Br J Gen Pract. 2018 Jan;68(666):6-7. doi: 10.3399/bjgp17X693965. No abstract available.

7.

In-depth PtdIns(3,4,5)P3 signalosome analysis identifies DAPP1 as a negative regulator of GPVI-driven platelet function.

Durrant TN, Hutchinson JL, Heesom KJ, Anderson KE, Stephens LR, Hawkins PT, Marshall AJ, Moore SF, Hers I.

Blood Adv. 2017 Jun 13;1(14):918-932. doi: 10.1182/bloodadvances.2017005173.

8.

The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin αIIbβ3 Outside-in Signaling.

Battram AM, Durrant TN, Agbani EO, Heesom KJ, Paul DS, Piatt R, Poole AW, Cullen PJ, Bergmeier W, Moore SF, Hers I.

J Biol Chem. 2017 Feb 3;292(5):1691-1704. doi: 10.1074/jbc.M116.746867. Epub 2016 Nov 30.

9.

Identification of roles for the SNARE-associated protein, SNAP29, in mouse platelets.

Williams CM, Savage JS, Harper MT, Moore SF, Hers I, Poole AW.

Platelets. 2016 Jun;27(4):286-94. doi: 10.3109/09537104.2015.1100282. Epub 2015 Nov 20.

PMID:
26587753
10.

Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.

Blair TA, Moore SF, Hers I.

J Thromb Haemost. 2015 Aug;13(8):1479-93. doi: 10.1111/jth.13022. Epub 2015 Jun 25.

11.

Loss of the insulin receptor in murine megakaryocytes/platelets causes thrombocytosis and alterations in IGF signalling.

Moore SF, Williams CM, Brown E, Blair TA, Harper MT, Coward RJ, Poole AW, Hers I.

Cardiovasc Res. 2015 Jul 1;107(1):9-19. doi: 10.1093/cvr/cvv132. Epub 2015 Apr 22.

12.

Which patients with Parkinson's disease participate in clinical trials? One centre's experiences with a new cell based therapy trial (TRANSEURO).

Moore SF, Guzman NV, Mason SL, Williams-Gray CH, Barker RA.

J Parkinsons Dis. 2014;4(4):671-6. doi: 10.3233/JPD-140432.

PMID:
25170676
13.

Phosphoinositide 3-kinases p110α and p110β have differential roles in insulin-like growth factor-1-mediated Akt phosphorylation and platelet priming.

Blair TA, Moore SF, Williams CM, Poole AW, Vanhaesebroeck B, Hers I.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1681-8. doi: 10.1161/ATVBAHA.114.303954. Epub 2014 Jun 5.

PMID:
24903091
14.
15.

Predictors of Parkinson's disease dementia: towards targeted therapies for a heterogeneous disease.

Moore SF, Barker RA.

Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S104-7. doi: 10.1016/S1353-8020(13)70026-9. Review.

PMID:
24262158
16.

Dysfunction of the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway underlies ex vivo platelet hypoactivity in essential thrombocythemia.

Moore SF, Hunter RW, Harper MT, Savage JS, Siddiq S, Westbury SK, Poole AW, Mumford AD, Hers I.

Blood. 2013 Feb 14;121(7):1209-19. doi: 10.1182/blood-2012-05-431288. Epub 2012 Dec 13.

17.

Dual regulation of glycogen synthase kinase 3 (GSK3)α/β by protein kinase C (PKC)α and Akt promotes thrombin-mediated integrin αIIbβ3 activation and granule secretion in platelets.

Moore SF, van den Bosch MT, Hunter RW, Sakamoto K, Poole AW, Hers I.

J Biol Chem. 2013 Feb 8;288(6):3918-28. doi: 10.1074/jbc.M112.429936. Epub 2012 Dec 13.

18.

mTORC2 protein complex-mediated Akt (Protein Kinase B) Serine 473 Phosphorylation is not required for Akt1 activity in human platelets [corrected].

Moore SF, Hunter RW, Hers I.

J Biol Chem. 2011 Jul 15;286(28):24553-60. doi: 10.1074/jbc.M110.202341. Epub 2011 May 18. Erratum in: J Biol Chem. 2011 Sep 2;286(35):31062.

19.

NADPH oxidase NOX2 mediates rapid cellular oxidation following ATP stimulation of endotoxin-primed macrophages.

Moore SF, MacKenzie AB.

J Immunol. 2009 Sep 1;183(5):3302-8. doi: 10.4049/jimmunol.0900394.

20.

Species and agonist dependent zinc modulation of endogenous and recombinant ATP-gated P2X7 receptors.

Moore SF, Mackenzie AB.

Biochem Pharmacol. 2008 Dec 15;76(12):1740-7. doi: 10.1016/j.bcp.2008.09.015. Epub 2008 Sep 20.

PMID:
18848528
21.

A key role for redox signaling in rapid P2X7 receptor-induced IL-1 beta processing in human monocytes.

Hewinson J, Moore SF, Glover C, Watts AG, MacKenzie AB.

J Immunol. 2008 Jun 15;180(12):8410-20.

22.

Murine macrophage P2X7 receptors support rapid prothrombotic responses.

Moore SF, MacKenzie AB.

Cell Signal. 2007 Apr;19(4):855-66. Epub 2006 Dec 18.

PMID:
17175137
23.

Alterations in calcium-mediated signal transduction after traumatic injury of cortical neurons.

Weber JT, Rzigalinski BA, Willoughby KA, Moore SF, Ellis EF.

Cell Calcium. 1999 Dec;26(6):289-99.

PMID:
10668567
24.

The biodisposition and metabolism of anandamide in mice.

Willoughby KA, Moore SF, Martin BR, Ellis EF.

J Pharmacol Exp Ther. 1997 Jul;282(1):243-7.

PMID:
9223560
25.

Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin.

Ellis EF, Moore SF, Willoughby KA.

Am J Physiol. 1995 Dec;269(6 Pt 2):H1859-64.

PMID:
8594893
26.

Endothelial and nonendothelial cyclooxygenase mediate rabbit pial arteriole dilation by bradykinin.

Copeland JR, Willoughby KA, Tynan TM, Moore SF, Ellis EF.

Am J Physiol. 1995 Jan;268(1 Pt 2):H458-66.

PMID:
7530923
27.

"Composite" tumor--mixed squamous cell and small-cell anaplastic carcinoma of the larynx.

Chen DA, Mandell-Brown M, Moore SF, Johnson JT.

Otolaryngol Head Neck Surg. 1986 Jul;95(1):99-103.

PMID:
3033580
28.

Pre- and intraoperative localization of small bowel arteriovenous malformation.

Reed DK, Porter LE, Zajko AB, Moore SF, Bron KM, Van Thiel DH.

J Clin Gastroenterol. 1986 Apr;8(2):166-70.

PMID:
3489031
29.

EEG measures of alternative strategies used by subjects to solve block designs.

Wogan M, Moore SF, Epro R, Harner RN.

Int J Neurosci. 1981;12(1):25-8. No abstract available.

PMID:
7203817
30.

A note on the confounding of personality and social class characteristics in research on premature termination. A reply to Garfield.

Stern SL, Moore SF, Gross SJ.

J Consult Clin Psychol. 1977 Jun;45(3):486-8. No abstract available.

PMID:
864065
31.

The hyperkinetic child syndrome: the need for reassessment.

Cole SO, Moore SF.

Child Psychiatry Hum Dev. 1976 Winter;7(2):103-12.

PMID:
1030661
32.

Confounding of personality and social class characteristics in research on premature termination.

Stern SL, Moore SF, Gross SJ.

J Consult Clin Psychol. 1975 Jun;43(3):341-4. No abstract available.

PMID:
1159121
33.

Influence of critical signal regularity, stimulus event matrix, and cognitive style on vigilance performance.

Moore SF, Gross SJ.

J Exp Psychol. 1973 Jun;99(1):137-9. No abstract available.

PMID:
4714075
34.

Subject-task interaction in selective attention research.

Gross SJ, Moore SF, Stern SL.

Percept Mot Skills. 1973 Feb;36(1):259-62. No abstract available.

PMID:
4686719
35.

The scarred cervix in pregnancy and labor.

Gibbs CE, Moore SF.

GP. 1968 Mar;37(3):85-7. No abstract available.

PMID:
5651320
36.

APPENDICEAL CARCINOID TUMORS IN PREGNANCY.

BERRIOS JR, DUNNIHOO DR, GIBBS CE, MOORE SF.

Obstet Gynecol. 1965 Sep;26:428-31. No abstract available.

PMID:
14341218
37.

THE VALUE OF THE SYMPTOM TO THE DEPRESSED GYNECOLOGIC PATIENT.

MOORE SF Jr.

GP. 1965 Jan;31:100-5. No abstract available.

PMID:
14216294
38.

A COMPARATIVE STUDY OF ANTIDEPRESSANT AGENTS IN THE TREATMENT OF GYNECOLOGICAL SYMPTOMS.

MOORE SF Jr.

Psychosomatics. 1964 Jul-Aug;5:240-4. No abstract available.

PMID:
14192669
39.

Therapy of psychosomatic symptoms in gynecology, an evaluation of chlordiazepoxide.

MOORE SF Jr.

Curr Ther Res Clin Exp. 1962 May;4:249-57. No abstract available.

PMID:
14475720
40.

Trichomonal vaginitis: an emotionally conditioned symptom.

MOORE SF Jr, SIMPSON JW.

South Med J. 1956 Dec;49(12):1495-501. No abstract available.

PMID:
13380611
41.

Acute infections complicating pregnancy; panel discussion.

MOORE SF Jr, DIPPEL AL, McDONALD RP, MENGERT WF, TAYLOR ES.

Tex State J Med. 1954 Dec;50(12):796-803. No abstract available.

PMID:
13216694
42.

The emotional component in Trichomonas vaginitis.

MOORE SF Jr, SIMPSON JW.

Am J Obstet Gynecol. 1954 Oct;68(4):974-9; discussion, 979-80. No abstract available.

PMID:
14349313
43.

Analysis of cesarean sections in private hospital from 1938 to 1948.

SANTA CRUZ EW, MOORE SF Jr.

Tex State J Med. 1950 Oct;46(10):751-4. No abstract available.

PMID:
14782192
44.

Rh factors and their relation to obstetrics.

MOORE SF Jr.

Tex State J Med. 1947 Sep;43(5):307-11. No abstract available.

PMID:
20344635
45.

Symposium on the Rh factor.

MOORE SF Jr, HILL JM, et al.

Tex State J Med. 1947 Sep;43(5):307-20. No abstract available.

PMID:
20261610

Supplemental Content

Loading ...
Support Center